세계의 염산 페닐레프린 시장 : 용도별, 방법별, 사용별, 예측(2023-2032년)

Phenylephrine Hydrochloride Market size is poised to expand at 7.7% CAGR from 2023-2032, driven by the surge in the number of allergies and environmental sensitivities worldwide. With more individuals experiencing allergic reactions to environmental factors, the demand for effective decongestant medications containing phenylephrine hydrochloride is rising. The ability to alleviate nasal congestion associated with allergic response is contributing to the increasing adoption of phenylephrine hydrochloride in the production of allergy relief formulations.

Furthermore, the ongoing R&D efforts aimed at improving formulations and delivery methods for medications containing phenylephrine hydrochloride are projected to propel market growth. To cite an instance, in May 2023, Eyenovia, Inc. received approval from the U.S. FDA for its Mydcombi, a 1%/2.5% tropicamide and phenylephrine hydrochloride ocular spray used in mydriasis for diagnostic procedures and in cases with desired short-term pupil dilation.

The phenylephrine hydrochloride industry is segmented into application, mode, use, and region.

As per mode, the market share from the contract manufacturing segment is anticipated to record 7.9% CAGR from 2023-2032. Contract manufacturing offers pharmaceutical companies a strategic approach to streamline production and optimize costs. Additionally, outsourcing the manufacturing processes to specialized contract manufacturers ensures efficient production, quality compliance, and scalability. This mode also allows pharmaceutical firms to focus on R&D activities while leveraging the expertise of contract manufacturers for timely and cost-effective production of phenylephrine hydrochloride-based medications.

In terms of application, the phenylephrine hydrochloride industry from the allergic reaction segment generated substantial revenue in 2022 and is poised to depict 7% growth rate from 2023 to 2032. This can be attributed to increasing use in medications for relieving nasal congestion associated with allergic reactions. The rising prevalence of allergies, environmental factors, and the changing lifestyles is also surging the need for pharmaceuticals containing phenylephrine hydrochloride, thereby fueling the segment growth.

Regionally, the Asia Pacific phenylephrine hydrochloride market is anticipated to exhibit 8.1% CAGR from 2023-2032 driven by the expanding pharmaceutical and healthcare sectors. The rising prevalence of respiratory conditions and the incessant need for decongestant medications is leading to the increased demand for phenylephrine hydrochloride. Additionally, the rising population, urbanization, and the changing lifestyles across major APAC countries are fueling the preference for over-the-counter medications, further boosting the regional industry outlook.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market definition & scope
• 1.2 Base estimates & calculations
• 1.3 Forecast parameters
• 1.4 COVID-19 impact analysis at global level
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Global phenylephrine hydrochloride industry 360 degree synopsis, 2018 - 2032
  • 2.1.1 Business trends
  • 2.1.2 Regional trends
  • 2.1.3 Application trends
  • 2.1.4 Mode trends
  • 2.1.5 Use trends

Chapter 3 Phenylephrine Hydrochloride Industry Insights

• 3.1 Industry ecosystem
• 3.2 COVID-19 impact analysis
• 3.3 Regulatory landscape
  • 3.3.1 U.S.
  • 3.3.2 Europe
• 3.4 Pricing analysis, by region
  • 3.4.1 Selling price in USD per kg
• 3.5 Innovation & sustainability
• 3.6 Industry impact forces
  • 3.6.1 Growth drivers
    • 3.6.1.1 Increasing applications of Phenylephrine HCL
    • 3.6.1.2 Increasing prevalence of respiratory conditions and allergies
  • 3.6.2 Industry pitfalls & challenges
    • 3.6.2.1 Availability of alternative treatment options and other decongestant
• 3.7 Growth potential analysis
  • 3.7.1 By application
  • 3.7.2 By mode
  • 3.7.3 By use
• 3.8 Porter's analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
  • 4.1.1 Unichem Laboratories
  • 4.1.2 Divi's Laboratories Limited
  • 4.1.3 VBShilpa
• 4.2 Competitive positioning matrix, 2022
• 4.3 Strategic outlook matrix
• 4.4 Company share analysis, 2022
  • 4.4.1 Global
  • 4.4.2 North America
  • 4.4.3 Europe
  • 4.4.4 Asia Pacific
• 4.5 Production capacity
• 4.6 List of top 20 end consumers with contact details/email id

Chapter 5 Phenylephrine Hydrochloride Market, By Application, 2018 - 2032 (USD Million)

• 5.1 Key trends, by application
• 5.2 Nasal decongestion
• 5.3 Cold
• 5.4 Eye diseases
• 5.5 Hypotension
• 5.6 Allergic reaction
• 5.7 Other applications

Chapter 6 Phenylephrine Hydrochloride Market, By Mode, 2018 - 2032 (USD Million)

• 6.1 Key trends, by mode
• 6.2 In-house manufacturing
• 6.3 Contract manufacturing

Chapter 7 Phenylephrine Hydrochloride Market, By Use, 2018 - 2032 (USD Million)

• 7.1 Key trends, by use
• 7.2 Human
• 7.3 Veterinary

Chapter 8 Phenylephrine Hydrochloride Market, By Region, 2018 - 2032 (USD Million)

• 8.1 Key trends, by region
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 France
  • 8.3.2 Italy
  • 8.3.3 Germany
  • 8.3.4 UK
  • 8.3.5 Russia
  • 8.3.6 Spain
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 South Korea
  • 8.4.5 Australia
  • 8.4.6 Malaysia
  • 8.4.7 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Rest of Latin America
• 8.6 MEA
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Rest of MEA

Chapter 9 Company Profiles

• 9.1 Aarti Pharmalabs Limited
• 9.2 SNA Healthcare Private Limited
• 9.3 Ralington Pharma
• 9.4 Cornileus Pharmaceuticals (P) Ltd.
• 9.5 Shenzhen Oriental Pharmaceutical Co. Ltd.
• 9.6 Unichem Laboratories Ltd.
• 9.7 Kavya Pharma
• 9.8 Transo-Pharm
• 9.9 LGM Pharma
• 9.10 Divi's Laboratories Limited